All terms in UPHENO

Label Id Description
cranial skeletal system development disrupted, abnormal ZP_0019021 [Abnormal(ly) disrupted (of) cranial skeletal system development.]
cranial skeletal system development process quality, abnormal ZP_0019559 [Abnormal(ly) process quality (of) cranial skeletal system development.]
heparan sulfate proteoglycan catabolic process GO_0030200 [The chemical reactions and pathways resulting in the breakdown of proteoglycan containing heparan sulfate, any member of a group of glycosaminoglycans that have repeat units consisting of alternating alpha-(1->4) linked hexuronic acid and glucosamine residues, the former being a mixture of sulfated and nonsulfated D-glucuronic and L-iduronic acids, and the latter being either sulfated or acetylated on its amino group as well as sulfated on one of its hydroxyl groups.]
proteoglycan catabolic process GO_0030167 [The chemical reactions and pathways resulting in the breakdown of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans.]
sulfur compound catabolic process GO_0044273 [The chemical reactions and pathways resulting in the breakdown of compounds that contain sulfur, such as the amino acids methionine and cysteine or the tripeptide glutathione.]
abnormal endocrine pancreas morphology UPHENO_0087931 [Any unspecified morphological anomaly of part of the endocrine pancreas, such as, for example, abnormal shape or colour.]
abnormal endocrine system morphology UPHENO_0076812 [Any unspecified morphological anomaly of part of the endocrine system, such as, for example, abnormal shape or colour.]
CoPA decreased process quality axon extension involved in axon guidance, abnormal ZP_0019022 [Abnormal(ly) decreased process quality (of) CoPA of axon extension involved in axon guidance.]
decreased qualitatively biological_process in central nervous system UPHENO_0083689 [Decreased qualitatively biological_process in central nervous system.]
axon extension involved in axon guidance decreased process quality, abnormal ZP_0006364 [Abnormal(ly) decreased process quality (of) axon extension involved in axon guidance.]
decreased qualitatively axon extension involved in axon guidance in independent continuant UPHENO_0043329 [Decreased qualitatively axon extension involved in axon guidance in independent continuant.]
potassium ion transmembrane transporter activity GO_0015079 [Enables the transfer of potassium ions (K+) from one side of a membrane to the other.]
abnormal aorta endothelium morphology UPHENO_0087932 [Any unspecified morphological anomaly of part of the aorta endothelium, such as, for example, abnormal shape or colour.]
abnormal aorta morphology UPHENO_0076809 [Any unspecified morphological anomaly of part of the aorta, such as, for example, abnormal shape or colour.]
abnormal blood vessel endothelium morphology UPHENO_0087053 [Any unspecified morphological anomaly of part of the blood vessel endothelium, such as, for example, abnormal shape or colour.]
cell cycle G1/S phase transition GO_0044843 [The cell cycle process by which a cell in G1 phase commits to S phase.]
meiotic interphase II GO_0044844 [The cell cycle phase which begins at the end of meiosis I cytokinesis and ends when meiosis II prophase begins. During meiotic interphase II no DNA replication takes place, but the centrioles duplicate and spindle fibres emerge.]
meiosis II cell cycle phase GO_0098765 [A meiotic cell cycle phase that occurs after meiosis I (the first meiotic nuclear division).]
meiotic interphase GO_0051328 [The cell cycle phase which begins after cytokinesis and ends when meiotic prophase begins. Meiotic cells have an interphase after each meiotic division, but only interphase I involves replication of the cell's DNA.]
abnormal islet of Langerhans morphology UPHENO_0087937 [Any unspecified morphological anomaly of part of the islet of Langerhans, such as, for example, abnormal shape or colour.]